Skin rash and splinter hemorrhages from ganciclovir

Sandra Lorenzi, A. D'Antuono, M. Iorizzo, Antonella Tosti

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Ganciclovir is a nucleotide-analogue similar to acyclovir, which has an in vitro activity against herpes simplex type 1, herpes simplex type 2 and varicella zoster virus. Numerous studies suggest that ganciclovir has clinical efficacy against cytomegalovirus disease, as well as an in vivo antiviral effect, and that this agent reduces morbidity of serious cytomegalovirus infections in immuno-compromised patients. Generalised cutaneous rash associated with ganciclovir therapy has rarely been reported in literature.

Original languageEnglish
Pages (from-to)177-178
Number of pages2
JournalJournal of Dermatological Treatment
Volume14
Issue number3
DOIs
StatePublished - Sep 1 2003
Externally publishedYes

Fingerprint

Ganciclovir
Exanthema
Herpes Simplex
Hemorrhage
Human Herpesvirus 3
Acyclovir
Cytomegalovirus Infections
Cytomegalovirus
Antiviral Agents
Nucleotides
Morbidity
Therapeutics

Keywords

  • Ganciclovir
  • HIV
  • Skin rash
  • Splinter hemorrhages

ASJC Scopus subject areas

  • Dermatology

Cite this

Skin rash and splinter hemorrhages from ganciclovir. / Lorenzi, Sandra; D'Antuono, A.; Iorizzo, M.; Tosti, Antonella.

In: Journal of Dermatological Treatment, Vol. 14, No. 3, 01.09.2003, p. 177-178.

Research output: Contribution to journalArticle

Lorenzi, Sandra ; D'Antuono, A. ; Iorizzo, M. ; Tosti, Antonella. / Skin rash and splinter hemorrhages from ganciclovir. In: Journal of Dermatological Treatment. 2003 ; Vol. 14, No. 3. pp. 177-178.
@article{f6396e5c60dd4fbd91fdd97a040b792c,
title = "Skin rash and splinter hemorrhages from ganciclovir",
abstract = "Ganciclovir is a nucleotide-analogue similar to acyclovir, which has an in vitro activity against herpes simplex type 1, herpes simplex type 2 and varicella zoster virus. Numerous studies suggest that ganciclovir has clinical efficacy against cytomegalovirus disease, as well as an in vivo antiviral effect, and that this agent reduces morbidity of serious cytomegalovirus infections in immuno-compromised patients. Generalised cutaneous rash associated with ganciclovir therapy has rarely been reported in literature.",
keywords = "Ganciclovir, HIV, Skin rash, Splinter hemorrhages",
author = "Sandra Lorenzi and A. D'Antuono and M. Iorizzo and Antonella Tosti",
year = "2003",
month = "9",
day = "1",
doi = "10.1080/09546630310015395",
language = "English",
volume = "14",
pages = "177--178",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Skin rash and splinter hemorrhages from ganciclovir

AU - Lorenzi, Sandra

AU - D'Antuono, A.

AU - Iorizzo, M.

AU - Tosti, Antonella

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Ganciclovir is a nucleotide-analogue similar to acyclovir, which has an in vitro activity against herpes simplex type 1, herpes simplex type 2 and varicella zoster virus. Numerous studies suggest that ganciclovir has clinical efficacy against cytomegalovirus disease, as well as an in vivo antiviral effect, and that this agent reduces morbidity of serious cytomegalovirus infections in immuno-compromised patients. Generalised cutaneous rash associated with ganciclovir therapy has rarely been reported in literature.

AB - Ganciclovir is a nucleotide-analogue similar to acyclovir, which has an in vitro activity against herpes simplex type 1, herpes simplex type 2 and varicella zoster virus. Numerous studies suggest that ganciclovir has clinical efficacy against cytomegalovirus disease, as well as an in vivo antiviral effect, and that this agent reduces morbidity of serious cytomegalovirus infections in immuno-compromised patients. Generalised cutaneous rash associated with ganciclovir therapy has rarely been reported in literature.

KW - Ganciclovir

KW - HIV

KW - Skin rash

KW - Splinter hemorrhages

UR - http://www.scopus.com/inward/record.url?scp=0141989718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141989718&partnerID=8YFLogxK

U2 - 10.1080/09546630310015395

DO - 10.1080/09546630310015395

M3 - Article

C2 - 14522628

AN - SCOPUS:0141989718

VL - 14

SP - 177

EP - 178

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 3

ER -